Actively Recruiting
UWCCC Molecular Tumor Board Registry
Led by University of Wisconsin, Madison · Updated on 2026-04-13
10000
Participants Needed
1
Research Sites
674 weeks
Total Duration
On this page
Sponsors
U
University of Wisconsin, Madison
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.
CONDITIONS
Official Title
UWCCC Molecular Tumor Board Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinically suspected or histologically confirmed solid or hematological malignancy
- Undergoing genetic testing of tumor
- Ability to understand written informed consent document
- Willingness to sign written informed consent document
You will not qualify if you...
- Pediatric patients (age <18 years) will be excluded due to a lack of expertise on the molecular tumor committee
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States, 53792
Actively Recruiting
Research Team
C
Cancer Connect
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here